Justia U.S. Federal Circuit Court of Appeals Opinion Summaries

by
The U.S. Department of Commerce initiated an antidumping duty investigation on certain tapered roller bearings (TRBs) from China, 19 U.S.C. 1673, and established a country-wide anti-dumping duty for TRBs from China. In 2009, Commerce revised the rate to 92.84%. Since 2017, ZMC had been granted separate rate status. An interested domestic party requested a review of ZMC’s 2016-2017 entries and submitted data indicating de facto control of ZMC by the government. In response to a questionnaire issued by Commerce, ZMC provided details about its corporate structure.After assessing ZMC’s corporate structure, Commerce preliminarily found that ZMC failed to rebut the presumption of de facto government control over its export activities. The Court of International Trade held that Commerce erred in rejecting a revised translation of Articles of Association. On remand, Commerce reviewed the revised translation but maintained its determination that ZMC failed to rebut the presumption of de facto government control. The Trade Court affirmed. The Federal Circuit affirmed. Commerce’s determination that ZMC was not entitled to a separate rate was reasonable and supported by substantial evidence because a labor union is the majority shareholder with significant rights over ZMC and has overlapping membership with the employee stock-ownership committee. View "Zhejiang Machinery Import & Export Corp. v. United States" on Justia Law

by
Charger filed an intent-to-use application to register SPARK LIVING on the Principal Register for leasing of real estate; real estate listing; real estate service, namely, rental property management. The examining attorney refused registration under the Lanham Act, 15 U.S.C. 1052(d), on grounds of a likelihood “to cause confusion, or to cause mistake, or to deceive with an earlier registered mark.” The earlier registered mark, SPARK, was registered for “[r]eal estate services, namely, rental brokerage, leasing, and management of commercial property, offices and office space.” Charger amended its description of services to only cover residential real estate services, then disclaimed the term “LIVING,” and again amended the description to “specifically” exclude commercial property and office space—the services of the registrant’s mark. The examining attorney maintained the refusal.The Trademark Trial and Appeal Board and Federal Circuit affirmed, as supported by substantial evidence the refusal to register Charger’s mark based on likelihood of confusion. The Board addressed five of the “Dupont factors”: similarity or dissimilarity of the marks, the nature of the goods or services, established, likely-to-continue trade channels, conditions under which and buyers to whom sales are made, and strength of the mark, focusing on the similarity or dissimilarity of the marks as well as the goods or services. View "In Re Charger Ventures LLC" on Justia Law

by
Rotigotine is used to treat Parkinson’s disease, which causes difficulty swallowing and slow transit times through intestines, which can frustrate oral treatments. Transdermal therapeutic systems deliver drugs through the patient’s skin and avoid those complications. In 2007, UCB invented and marketed Neupro®, the first FDA-approved patch treatment for Parkinson’s disease. Original Neupro® is covered by several UCB patents, including the Muller patents, which claim priority to an application filed in 1999. The Muller patents are listed in the FDA’s “Orange Book,” as covering reformulated Neupro®.In 2013, Actavis submitted an Abbreviated New Drug Application (ANDA) for FDA approval of a generic transdermal rotigotine patch. UCB sued for infringement. The district court granted UCB an injunction preventing approval of Actavis’s ANDA until March 2021, when the Muller patent expired. In 2018 UCB filed the patent application that matured into the 589 patent, claiming priority from a provisional application filed in 2009, entitled “Polyvinylpyrrolidone for the Stabilization of a Solid Dispersion of the Non-Crystalline Form of Rotigotine.” UCB again filed suit, asserting the 589 patent, to delay FDA approval of a generic for nine additional years.The district court found that the Muller patents anticipate all asserted claims and that the asserted claims would have been obvious in view of multiple prior art references, including the Muller patents. The Federal Circuit affirmed the judgment of invalidity of the 589 patent. The district court’s fact findings on overlapping ranges, teaching away, unexpected results, and commercial success are not clearly erroneous, View "UCB, Inc. v. Actavis Laboratories UT, Inc." on Justia Law

by
The district court dismissed Sanderling’s infringement suit due to the asserted claims’ lack of patent-eligible subject matter under 35 U.S.C. 101. The patents at issue share the title “Dynamic Promotional Layout Management and Distribution Rules,” and are directed to a method using distribution rules to load digital image branding functions to users when certain conditions are met. The patents share a common specification, which describes the digital image branding function as a transformation, using, for example, an icon or a filter, that displays in a client terminal for the user to apply to a digital image. A distribution rule “is a rule used in determining how to target a group of end users, for instance, a rule that determines that only a group of end users having certain characteristics and/or match a certain requirement.”The Federal Circuit affirmed. The claims are directed to an abstract idea, not a specific improvement in computer functionality. The claims describe the use of computers as a tool to identify when a condition is met and then to distribute information based on satisfaction of that condition. The elements of the representative claim, individually and as an ordered combination, do not constitute an inventive concept. View "Sanderling Management Ltd. v. Snap Inc." on Justia Law

by
Sequoia’s patent is directed to “a method for managing a logical volume for minimizing a size of metadata and supporting dynamic online resizing,” and “a computer-readable recording medium storing a program or data structure for embodying the method.” The patent describes a preferred embodiment that has three storage virtualizations: extents, disk partitions, and logical volume. The accused product, Red Hat’s software tool, can create and resize logical volumes with units smaller than a whole disk partition, such as extents. Red Hat’s petitions for inter partes reviews were rejected.In infringement litigation, the Federal Circuit reversed a finding of invalidity based on the construction of “computer-readable recording medium” to include transitory media (signals or waves). Transitory media are ineligible statutory subject matter under 35 U.S.C. 101. The district court erred in relying on extrinsic evidence that was clearly at odds with the intrinsic evidence.The Federal Circuit affirmed a finding of noninfringement, upholding the constructions of a “disk partition” to mean a “section of a disk that is a minimum unit of a logical volume” and a “logical volume” to mean an “extensible union of more than one disk partition, the size of which is resized in disk partition units.” View "Sequoia Technology, LLC v. Dell Inc." on Justia Law

by
In 2015, the Department of Commerce received petitions from domestic producers requesting that Commerce impose antidumping and countervailing duties on corrosion-resistant steel (CORE) exports from China. Commerce initiated investigations and published orders. In 2019, Commerce initiated investigations to determine whether exports of CORE from the UAE were circumventing the China CORE orders. The Court of International Trade judgment affirmed the subsequent circumvention determination. In making its determination, Commerce analyzed the circumvention factors and subfactors provided by 19 U.S.C. 1677j(b).The Federal Circuit affirmed Commerce’s circumvention determination as reasonable and supported by substantial evidence with respect to “pattern of trade,” “level of investment,” “nature of the production process,” and “extent of production facilities.” Commerce’s analysis of the “value-added” subfactor was erroneous because Commerce did not reasonably explain why it rejected financial data that were purported to show a significant value added but the error was harmless because it was limited to a single factual finding within a multi-factor test. View "Al Ghurair Iron & Steel LLC v. United States" on Justia Law

by
HCM sued Philip Morris for allegedly infringing at least one claim of HCM’s patent, which is directed to an electronic nicotine-delivery device. Philip Morris manufactures the IQOS electronic nicotine-delivery system, which “heats tobacco-filled sticks wrapped in paper [HeatSticks] to generate a nicotine-containing aerosol.” Philip Morris markets IQOS as a “heat-not-burn” system; the tobacco is heated at a low enough temperature that the tobacco does not burn, therefore, in Philip Morris’s view, preventing combustion.Philip Morris argued that an exhibit HCM attached to its original complaint conclusively demonstrated that IQOS does not initiate a combustion reaction as required by the asserted claims. The district court agreed that a Modified Risk Tobacco Product Application that Philip Morris submitted to the FDA when it sought a modified risk order to sell IQOS established that IQOS did not initiate a combustion reaction and thus did not infringe the asserted claims. The court granted Philip Morris attorneys’ fees under 35 U.S.C. 285.The Federal Circuit reversed. HCM’s original and amended complaints recite sufficient allegations to raise a facially plausible case of patent infringement and specifically rejected the notion that IQOS does not initiate a combustion reaction. View "Healthier Choices Management Corp. v. Philip Morris USA, Inc." on Justia Law

by
Arbutus’s 127 patent states that its purpose is to allow for more efficient methods and compositions for introducing nucleic acids into cells and methods of downregulating gene expression. The invention is, in part, the “surprising discovery” of the Morphology Limitation when one controls two factors: the lipid compositions of a SNALP formulation and formation process.Moderna sought inter partes review (IPR), arguing that the 069 patent, which was filed in April 2009, and claims priority to an application filed in April 2008, anticipated every claim. The 069 patent lists five inventors, three of which are listed on the 127 patent. The 069 patent, its child patent (435 patent), and the 127 patent are commonly owned by Arbutus. While the 127 patent was filed during the pendency of the 069 patent, it does not claim priority to it.The Patent Trial and Appeal Board found claims 1–22 of the 127 patent invalid as anticipated. The Federal Circuit affirmed. The Board’s determination that the Morphology Limitation of claim 1 is inherently anticipated by the 069 patent is supported by substantial evidence as is its finding that the 069 patent and its incorporated references describe nucleic acid-lipid particles and disclose these amounts as an inherent property of the formulations. View "Arbutus Biopharma Corp. v. Modernatx, Inc." on Justia Law

by
Pickett served in the Army from 1969-1971, including service in Vietnam. In 2004, sought service-connected compensation for an anxiety disorder, which he attributed to exposure to Agent Orange or other herbicides. The VA eventually granted Pickett service-connected compensation for post-traumatic stress disorder (PTSD) and coronary artery disease (CAD) effective 2004. Pickett appealed, seeking a total disability rating based on individual unemployability (TDIU), starting in 2007, the date he last worked. A 2013 VA decision denied the application. The VA notified Pickett that he had a year to appeal. He did not appeal. A 2014 decision listed the 2013 decision and proposed decreasing Pickett’s PTSD rating. Pickett only challenged the proposed reduction.In 2017, Pickett filed a supplemental claim and new TDIU application, again citing service-connected CAD and PTSD. The VA awarded Pickett TDIU due solely to PTSD and increased his ratings, effective January 2017. Pickett filed a notice of disagreement, citing 38 C.F.R. 3.156(b), and arguing he was entitled to “an extra-schedular total rating,” which could include TDIU, effective from 2007.The Board of Veterans’ Appeals, Veterans’ Court, and Federal Circuit denied Pickett an earlier effective date. Pickett’s failure to perfect an appeal following the 2013 or 2014 decisions meant that his 2004 claim for the maximum CAD evaluation—including entitlement to TDIU—became final by 2017. The finalized claim could not provide a basis for an earlier entitlement to TDIU. View "Pickett v. McDonough" on Justia Law

by
SAS creates and sells software used for data access, management, analysis, and presentation. The SAS System allows users to input user-written programs into its graphical user interface to complete analytics tasks. Users write commands in SAS’s programming language. An earlier version of the SAS System is in the public domain. SAS has copyright registrations that cover various aspects of the SAS System. WPL created a competitor, the WPS System, which uses the SAS Language to allow users to run user-written programs to complete analytics tasks such as data access, management, analysis, and presentation. SAS sued WPL, alleging copyright infringement of the SAS System and SAS user manuals.The district court first concluded that SAS possessed valid copyright registrations covering SAS’s asserted software, then determined that WPL provided evidence that showed the software program elements were not within the scope of protection under copyright law. Applying the abstraction-filtration-comparison test, the district court determined that SAS failed to establish copyrightability.The Federal Circuit affirmed the dismissal of the suit. The court interpreted “copyrightability” as meaning whether the specific elements of a copyrighted work that are asserted in a copyright infringement action fall within the scope of protection extended to that particular work under copyright law. The district court acted properly in conducting a pretrial “Copyrightability Hearing.” View "SAS Institute, Inc. v. World Programming Ltd." on Justia Law